| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Catalent, Inc. | SVP, Ops, Biologics Europe | Common Stock | 5,676 | $211,034 | $37.18 | 01 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000159678323000021-gargiulo-mario-2023-05-01 | Catalent, Inc. | 01 May 2023 | 1 | -$33,805 | 4 | SVP, Ops, Biologics Europe | 03 May 2023, 18:58 |
| /report/000159678322000114-gargiulo-mario-2022-08-24 | Catalent, Inc. | 24 Aug 2022 | 2 | -$163,421 | 4 | SVP Global Ops Biologics | 26 Aug 2022, 20:17 |
| /report/000159678322000066-gargiulo-mario-2022-07-26 | Catalent, Inc. | 26 Jul 2022 | 3 | -$103,586 | 4 | SVP Global Ops Biologics | 28 Jul 2022, 19:43 |
| /report/000159678322000043-gargiulo-mario-2022-06-10 | Catalent, Inc. | 10 Jun 2022 | 1 | -$12,578 | 4 | SVP Global Ops Large Molecule | 13 Jun 2022, 16:58 |
| /report/000159678321000187-gargiulo-mario-2021-10-28 | Catalent, Inc. | 28 Oct 2021 | 0 | $0 | 3 | SVP Global Ops Large Molecule | 02 Nov 2021, 12:22 |